KLWA
MRK icon

Kelly Lawrence W & Associates’s Merck MRK Stock Holding History

Kelly Lawrence W & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67,447
Closed -$7.66M – 175
2024
Q3 		$7.66M Buy
67,447
+624
+0.9% +$74.1K 1.73% 23
2024
Q2 		$8.27M Sell
66,823
-955
-1% -$123K 1.89% 24
2024
Q1 		$8.94M Sell
67,778
-2,630
-4% -$324K 2.04% 24
2023
Q4 		$7.68M Buy
70,408
+480
+0.7% +$49.8K 1.84% 22
2023
Q3 		$7.2M Sell
69,928
-575
-0.8% -$62K 1.93% 22
2023
Q2 		$7.77M Sell
70,503
-3,140
-4% -$357K 2.01% 22
2023
Q1 		$7.83M Sell
73,643
-1,890
-3% -$204K 2.12% 21
2022
Q4 		$8.38M Sell
75,533
-29,800
-28% -$3.05M 2.39% 20
2022
Q3 		$9.07M Sell
105,333
-465
-0.4% -$41.5K 2.53% 18
2022
Q2 		$9.65M Buy
105,798
+25
+0% +$2.22K 2.64% 18
2022
Q1 		$8.68M Buy
105,773
+2,130
+2% +$168K 1.85% 25
2021
Q4 		$7.94M Sell
103,643
-4,330
-4% -$345K 1.57% 24
2021
Q3 		$8.11M Buy
107,973
+30
+0% +$2.28K 1.71% 24
2021
Q2 		$8.39M Sell
107,943
-3,641
-3% -$271K 1.81% 24
2021
Q1 		$8.21M Buy
111,584
+31,865
+40% +$2.35M 1.94% 23
2020
Q4 		$6.22M Sell
79,719
-29,365
-27% -$2.25M 2.46% 19
2020
Q3 		$8.63M Sell
109,084
-71,678
-40% -$5.61M 2.57% 16
2020
Q2 		$13.3M Buy
180,762
+69,770
+63% +$5.25M 2.76% 16
2020
Q1 		$8.15M Sell
110,992
-22,725
-17% -$1.79M 1.98% 20
2019
Q4 		$11.6M Sell
133,717
-1,913
-1% -$157K 1.82% 24
2019
Q3 		$10.9M Sell
135,630
-2,620
-2% -$210K 1.82% 24
2019
Q2 		$11.1M Buy
138,250
+225
+0.2% +$17.2K 1.89% 24
2019
Q1 		$11M Sell
138,025
-1,677
-1% -$125K 1.98% 24
2018
Q4 		$10.2M Sell
139,702
-5,980
-4% -$422K 2.2% 21
2018
Q3 		$9.86M Buy
145,682
+733
+0.5% +$46.7K 1.62% 28
2018
Q2 		$8.39M Buy
144,949
+2,358
+2% +$133K 1.54% 29
2018
Q1 		$7.41M Buy
142,591
+367
+0.3% +$19.8K 1.4% 28
2017
Q4 		$7.64M Sell
142,224
-89,092
-39% -$4.94M 1.4% 29
2017
Q3 		$14.1M Buy
231,316
+1,223
+0.5% +$74.1K 2.69% 18
2017
Q2 		$14.1M Buy
230,093
+1,730
+0.8% +$105K 2.78% 13
2017
Q1 		$13.8M Buy
228,363
+3,100
+1% +$188K 2.86% 14
2016
Q4 		$12.7M Buy
225,263
+222,684
+8,635% +$13M 2.81% 16
2016
Q3 		$154K Buy
2,579
+78
+3% +$4.56K 0.03% 95
2016
Q2 		$138K Hold
2,501
– – 0.03% 105
2016
Q1 		$126K Hold
2,501
– – 0.03% 101
2015
Q4 		$126K Sell
2,501
-444
-15% -$22.4K 0.03% 103
2015
Q3 		$139K Sell
2,945
-2,096
-42% -$111K 0.03% 100
2015
Q2 		$273K Buy
5,041
+1,048
+26% +$58.8K 0.05% 83
2015
Q1 		$219K Hold
3,993
– – 0.05% 81
2014
Q4 		$216K Hold
3,993
– – 0.05% 85
2014
Q3 		$226K Sell
3,993
-209
-5% -$11.7K 0.05% 79
2014
Q2 		$231K Sell
4,202
-105
-2% -$5.73K 0.05% 82
2014
Q1 		$233K Buy
4,307
+325
+8% +$16.8K 0.05% 78
2013
Q4 		$190K Buy
+3,982
New +$182K 0.04% 82
2013
Q3 		– Sell
-3,982
Closed -$176K – 97
2013
Q2 		$176K Buy
+3,982
New +$178K 0.04% 77

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kelly Lawrence W & Associates's MRK Position: Q4 2024 in Review

Kelly Lawrence W & Associates sold out of Merck (MRK) in Q4 2024, closing a stake of 67,447 shares — an estimated $7.66M sold.

Kelly Lawrence W & Associates first reported a position in MRK in Q2 2013 and held it in 45 quarters. The position peaked at $14.1M in Q3 2017. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Kelly Lawrence W & Associates reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 67,447 Merck shares in Q4 2024, an estimated $7.66M.
  • Kelly Lawrence W & Associates first reported a position in Merck in Q2 2013 and held it in 45 quarters.
  • Kelly Lawrence W & Associates's Merck position peaked at $14.1M in Q3 2017.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2024, filed 13 Feb 2025.